MCA
ABBV icon

McGuire Capital Advisors’s AbbVie ABBV Stock Holding History

McGuire Capital Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$863K Sell
3,431
-13
-0.4% -$2.8K 0.47% 38
2026
Q1 		$749K Sell
3,444
-1,530
-31% -$339K 0.48% 39
2025
Q4 		$1.14M Buy
+4,974
New +$1.13M 0.72% 29

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

McGuire Capital Advisors's ABBV Position: Q2 2026 in Review

McGuire Capital Advisors reduced its AbbVie (ABBV) stake by 0.38% in Q2 2026, selling an estimated $2.8K and leaving 3,431 shares worth $863K. The position accounts for 0.47% of the portfolio, ranked #38.

McGuire Capital Advisors first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.14M in Q4 2025. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • McGuire Capital Advisors held 3,431 shares of AbbVie worth $863K as of Q2 2026.
  • McGuire Capital Advisors sold 13 AbbVie shares in Q2 2026, an estimated $2.8K.
  • AbbVie made up 0.47% of McGuire Capital Advisors's portfolio in Q2 2026, its #38 holding.
  • McGuire Capital Advisors first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • McGuire Capital Advisors's AbbVie position peaked at $1.14M in Q4 2025.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on McGuire Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.